Detalles de la búsqueda
1.
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Ann Surg Oncol
; 30(4): 2048-2056, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566258
2.
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
Br J Surg
; 110(11): 1502-1510, 2023 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467389
3.
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
Thorax
; 77(12): 1260-1267, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149582
4.
The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 29(9): 5830-5841, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650370
5.
Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
Ann Surg Oncol
; 29(11): 6566-6576, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35513588
6.
Predictive Ability of C-Reactive Protein in Detecting Short-Term Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cross-Sectional Study.
Ann Surg Oncol
; 28(1): 233-243, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524458
7.
Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
Ann Surg Oncol
; 26(13): 4222-4228, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31620941
8.
ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Ann Surg Oncol
; 30(4): 2057, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36719571
9.
Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
Clin Exp Med
; 24(1): 80, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642130
10.
Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers.
Eur J Surg Oncol
; 49(3): 611-618, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610896
11.
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536940
12.
Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO.
BMJ Open
; 12(6): e062907, 2022 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35732399
13.
Nasogastric- vs. percutaneous gastrostomy tube for prophylactic gastric decompression after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Pleura Peritoneum
; 6(2): 57-65, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179339
14.
Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
BMJ Open
; 9(5): e026779, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092657
15.
Mesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Ischemia and Reperfusion Injury.
J Immunol Res
; 2015: 202975, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26380314
Resultados
1 -
15
de 15
1
Próxima >
>>